Lv2
190 积分 2025-03-14 加入
Real‐World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group
1小时前
待确认
放射性皮炎诊疗专家共识
4天前
已完结
糖尿病足溃疡的局部处理
14天前
已完结
Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?
27天前
已完结
The minimal clinically important difference in allergic rhinitis
1个月前
已完结
[Expert consensus on the multidisciplinary integrated management of atopic dermatitis and its comorbidities(2026 edition)]
2个月前
已完结
Not just another klass (JAK) of inhibitors for allergies
2个月前
已完结
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
2个月前
已完结
P76.28 Phase II Study of the Efficacy of the EGFR Inhibitor Mefatinib in Patients with Advanced EGFR-mutant NSCLC
2个月前
已完结
Mefatinib as first-line treatment of EGFR sensitizing mutation-positive non-small-cell lung cancer: A phase III efficacy and biomarker study
2个月前
已关闭
皖公网安备34019202002308
